Steris | STE - Interest Expense On Debt


Steris reported $15.8M in Interest Expense on Debt for its fiscal quarter ending in June of 2026.





Interest Expense On Debt Change Date
3M USD 202M 12M Jun/2026
Accuray USD 2.88M 72K Dec/2024
Baxter International USD 78M 20M Mar/2026
Becton, Dickinson and Co. USD 132M 17M Jun/2026
Boston Scientific USD 96M 6M Jun/2026
CONMED USD 7.88M 823K Jun/2026
Cooper Companies USD 21.5M 600K Jun/2026
Dexcom USD 3.1M 1.1M Mar/2026
Ecolab USD 66.5M 16.4M Jun/2026
Edwards Lifesciences USD 30M 5.9M Jun/2026
Fortive USD 35.4M 3.8M Jun/2026
Getinge SEK 133M 31M Jun/2026
Globus Medical USD 5.49B 48.7M Jun/2026
Haemonetics USD 5.08M 2.32M Mar/2026
Idexx Laboratories USD 10.18M 2.44M Jun/2026
Inogen 1.03M 384K Mar/2025
Insulet USD 11M 3.7M Jun/2026
Integra LifeSciences USD 22.99M 529K Jun/2026
Intuitive Surgical USD 20.88B 765.6M Jun/2026
J&J USD 43M 25M Mar/2026
Olympus JPY 2.82B 2.31B Jun/2026
Orthofix International 4.68M 731K Sep/2025
Owens Minor USD 27.93M 1.1M Dec/2025
ResMed USD 8.79M 14.55M Sep/2025
Steris USD 15.8M 700K Jun/2026
Stryker USD 47.93B 1.64B Jun/2026
Tandem Diabetes Care USD 1.15B 808K Jun/2026
Teleflex USD 27.95M 2.24M Jun/2026
Thermo Fisher Scientific USD 354M 11M Mar/2026
Zimmer Biomet Holdings USD 22.8B 22.73B Jun/2026